Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00364650 · ClinicalTrials.gov registry record · NA
Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation
A NA study, sponsored by Swedish Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT00364650 is a NA study that has completed, run by Swedish Medical Center. The registered enrollment target is 44 participants.
The verdict
NCT00364650, a NA study, has completed, sponsored by Swedish Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
We hypothesize that the administration of a combination of high numbers of probiotic bacteria will maintain normal bowel function and significantly moderate or obviate Immunosuppression Associated Diarrhea following kidney transplantation.
Interventions
- OTHER Placebo
- DRUG Probiotic Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00364650
The ClinicalTrials.gov registry entry for NCT00364650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00364650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00364650 about?
NCT00364650 is a clinical study titled "Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation". We hypothesize that the administration of a combination of high numbers of probiotic bacteria will maintain normal bowel function and significantly moderate or obviate Immunosuppression Associated Diarrhea following kidney transplantation.
What is the current status of trial NCT00364650?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2006-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00364650?
The interventions under investigation include: Placebo (OTHER), Probiotic Supplement (DRUG).
Who is sponsoring clinical trial NCT00364650?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.